1. Home
  2. CELU vs ARKR Comparison

CELU vs ARKR Comparison

Compare CELU & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • ARKR
  • Stock Information
  • Founded
  • CELU 2016
  • ARKR 1983
  • Country
  • CELU United States
  • ARKR United States
  • Employees
  • CELU N/A
  • ARKR N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • ARKR Restaurants
  • Sector
  • CELU Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • CELU 42.2M
  • ARKR 36.0M
  • IPO Year
  • CELU N/A
  • ARKR N/A
  • Fundamental
  • Price
  • CELU $1.37
  • ARKR $9.55
  • Analyst Decision
  • CELU
  • ARKR
  • Analyst Count
  • CELU 0
  • ARKR 0
  • Target Price
  • CELU N/A
  • ARKR N/A
  • AVG Volume (30 Days)
  • CELU 97.9K
  • ARKR 11.6K
  • Earning Date
  • CELU 12-06-2024
  • ARKR 05-12-2025
  • Dividend Yield
  • CELU N/A
  • ARKR 1.84%
  • EPS Growth
  • CELU N/A
  • ARKR N/A
  • EPS
  • CELU N/A
  • ARKR N/A
  • Revenue
  • CELU $48,200,000.00
  • ARKR $181,046,000.00
  • Revenue This Year
  • CELU N/A
  • ARKR N/A
  • Revenue Next Year
  • CELU $233.89
  • ARKR N/A
  • P/E Ratio
  • CELU N/A
  • ARKR N/A
  • Revenue Growth
  • CELU 225.94
  • ARKR N/A
  • 52 Week Low
  • CELU $1.00
  • ARKR $8.88
  • 52 Week High
  • CELU $5.69
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • CELU 40.70
  • ARKR 39.09
  • Support Level
  • CELU $1.64
  • ARKR $9.41
  • Resistance Level
  • CELU $2.40
  • ARKR $10.79
  • Average True Range (ATR)
  • CELU 0.20
  • ARKR 0.62
  • MACD
  • CELU -0.02
  • ARKR 0.07
  • Stochastic Oscillator
  • CELU 0.00
  • ARKR 33.67

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: